| IPA-3 |
ENSG00000100181.17 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000118412.8 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000125804.9 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000149656.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000157306.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000171889.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000172965.10 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000174171.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000175701.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000175873.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000177640.11 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000177738.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000177822.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000178803.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000178977.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000179219.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000179743.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000179859.7 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000180139.10 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000180458.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000182648.7 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000184324.11 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000185203.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000185495.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000185837.3 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000185904.7 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000186019.10 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000187156.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000187904.3 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000188825.9 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000188825.9 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000189196.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000189419.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000196421.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000196960.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000196960.3 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000197463.8 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000203288.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000203288.3 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000203441.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000203496.4 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000203585.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000203645.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000203650.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000204588.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000204623.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000204706.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000204802.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000204815.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000204837.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000204929.7 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000204934.6 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000205181.5 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000205266.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000205500.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000205559.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000206113.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000211683.3 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000212978.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000213468.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000213863.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000213994.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000214049.6 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000214546.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000214546.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000214546.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000214548.10 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000214770.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000214773.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000215023.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000215190.4 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000215241.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000215256.3 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000215458.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000215866.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000221571.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000222035.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000223356.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000223462.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000223523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000223546.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000223571.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000223571.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000223635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000223652.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000223685.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000223704.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000223714.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000223745.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000223749.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000223759.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000223759.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000223774.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000223797.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000223799.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000223804.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000223821.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000223838.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000223882.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000223969.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000224020.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000224023.6 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000224043.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000224050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000224079.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000224142.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000224142.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000224157.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000224167.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000224174.2 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000224259.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000224272.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000224281.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000224329.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000224376.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000224409.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000224468.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000224468.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000224541.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000224577.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000224638.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000224638.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000224738.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000224789.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000224805.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000224822.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000224843.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000224863.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000224905.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000224934.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000224959.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000224977.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000225063.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000225075.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000225075.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000225075.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000225077.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000225177.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000225218.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000225278.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000225302.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000225313.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000225528.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000225535.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000225649.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000225675.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000225733.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000225745.4 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000225794.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000225815.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000225931.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000225956.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000225986.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000226009.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000226053.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000226167.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000226179.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000226245.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000226263.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000226302.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000226310.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000226310.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000226310.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000226312.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000226330.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000226367.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000226367.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000226386.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000226386.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000226416.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000226472.3 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000226578.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000226649.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000226684.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000226699.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000226754.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000226786.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000226786.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000226797.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000226816.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000226835.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000226876.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000226890.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000226900.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000227006.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000227006.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000227053.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000227110.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000227116.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000227116.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000227200.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000227245.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000227256.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000227279.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000227374.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000227374.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000227479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000227482.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000227484.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000227484.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000227502.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000227512.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000227512.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000227619.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000227627.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000227637.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000227702.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000227719.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000227741.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000227741.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000227811.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000227857.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000227877.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000227885.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000227888.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000227895.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000227945.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000227959.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000228021.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000228022.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000228044.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000228060.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000228124.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000228223.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000228251.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000228288.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000228293.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000228315.7 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000228323.2 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000228350.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000228350.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000228369.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000228386.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000228393.3 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000228412.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000228487.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000228548.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000228630.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000228649.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000228649.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000228686.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000228701.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000228784.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000228786.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000228802.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000228838.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000228889.2 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000228889.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000228952.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000229065.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000229065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000229081.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000229109.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000229118.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000229124.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000229162.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000229162.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000229167.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000229228.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000229236.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000229263.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000229431.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000229512.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000229525.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000229536.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000229563.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000229582.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000229654.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000229672.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000229672.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000229750.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000229776.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000229874.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000229896.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000229950.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000229951.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000229952.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000229955.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000229989.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000230013.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000230074.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000230140.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000230140.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000230184.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000230257.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000230262.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000230303.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000230310.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000230368.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000230392.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000230454.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000230487.3 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000230499.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000230530.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000230565.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000230606.6 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000230699.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000230724.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000230773.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000230815.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000230836.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000230922.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000231104.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000231170.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000231187.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000231193.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000231193.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000231233.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000231290.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000231291.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000231312.2 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000231324.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000231327.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000231393.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000231393.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000231429.2 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000231439.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000231441.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000231507.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000231521.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000231533.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000231551.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000231574.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000231599.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000231611.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000231611.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000231616.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000231636.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000231683.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000231704.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000231720.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000231769.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000231811.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000231830.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000231840.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000231851.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000231858.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000231863.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000231890.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000231908.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000231920.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000231969.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000231969.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000231992.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000231999.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000232021.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000232034.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000232110.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000232116.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000232224.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000232229.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000232295.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000232295.3 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000232396.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000232406.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000232412.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000232412.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000232455.2 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000232470.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000232542.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000232593.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000232611.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000232611.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000232636.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000232656.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000232656.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000232694.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000232721.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000232729.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000232732.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000232807.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000232874.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000232876.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000232876.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000232995.3 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000233008.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000233016.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000233030.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000233056.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000233080.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000233101.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000233117.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000233143.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000233203.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000233215.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000233230.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000233237.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000233340.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000233368.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000233396.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000233461.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000233483.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000233496.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000233532.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000233532.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000233547.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000233554.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000233559.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000233590.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000233593.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000233611.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000233665.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000233694.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000233776.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000233800.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000233852.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000233864.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000233926.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000233937.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000233942.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000233977.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000233993.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000234019.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000234028.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000234070.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000234091.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000234129.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000234134.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000234147.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000234149.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000234160.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000234183.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000234222.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000234230.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000234245.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000234252.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000234277.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000234283.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000234290.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000234318.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000234318.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000234350.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000234393.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000234432.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000234456.3 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000234459.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000234459.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000234478.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000234503.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000234509.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000234535.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000234572.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000234630.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000234650.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000234663.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000234705.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000234707.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000234741.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000234817.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000234818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000234945.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000234997.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000235007.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000235029.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000235052.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000235070.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000235131.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000235159.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000235159.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000235172.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000235209.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000235214.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000235246.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000235246.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000235313.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000235398.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000235398.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000235398.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000235398.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000235410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000235423.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000235445.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000235477.2 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000235530.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000235545.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000235560.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000235609.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000235726.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000235760.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000235770.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000235802.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000235802.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000235903.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000235908.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000235947.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000235999.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000236008.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000236066.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000236094.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000236137.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000236153.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000236209.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000236230.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000236308.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000236318.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000236377.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000236383.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000236390.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000236423.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000236472.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000236472.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000236499.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000236544.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000236545.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000236559.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000236601.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000236641.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000236703.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000236703.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000236703.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000236799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000236861.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000236896.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000236908.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000236933.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000236936.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000236943.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000236943.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000236943.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000236947.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000236983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000236983.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000236991.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000236991.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000237021.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000237094.7 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000237149.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000237152.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000237234.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000237253.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000237253.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000237281.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000237281.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000237343.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000237399.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000237424.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000237476.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000237491.4 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000237499.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000237520.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000237523.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000237587.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000237594.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000237594.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000237686.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000237689.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000237718.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000237738.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000237797.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000237852.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000237853.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000237857.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000237862.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000237883.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000237886.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000237886.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000237903.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000237903.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000237945.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000237950.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000237976.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000238005.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000238035.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000238039.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000238058.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000238068.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000238123.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000238198.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000238272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000238290.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000239265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000239377.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000239407.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000239467.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000239552.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000239828.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000239906.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000240207.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000240219.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000240219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000240449.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000240476.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000240710.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000240710.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000240731.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000240758.2 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000240875.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000240875.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000240915.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000240990.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000241014.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000241180.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000241180.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000241211.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000241211.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000241219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000241288.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000241481.2 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000241577.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000241772.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000242082.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000242154.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000242396.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000242767.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000243008.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000243018.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000243055.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000243368.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000243485.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000243533.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000243766.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000244041.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000244041.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000244063.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000244124.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000244161.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000244184.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000244198.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000244310.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000244327.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000244479.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000244513.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000244625.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000244676.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000244926.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000244998.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000245059.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000245060.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000245105.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000245105.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000245498.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000245522.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000245522.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000245532.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000245573.3 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000245651.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000245651.2 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000245667.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000246174.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000246308.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000246323.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000246331.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000246339.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000246363.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000246451.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000246451.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000246523.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000246627.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000246982.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000247095.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000247095.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000247373.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000247381.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000247624.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000247675.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000247675.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000247679.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000247765.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000247934.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000247970.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000248150.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000248165.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000248202.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000248215.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000248318.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000248323.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000248367.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000248479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000248489.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000248544.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000248668.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000248668.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000248677.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000248690.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000248740.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000248758.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000248758.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000248774.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000248779.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000248890.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000248973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000249061.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000249085.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000249196.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000249234.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000249252.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000249328.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000249379.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000249395.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000249417.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000249421.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000249492.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000249494.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000249502.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000249526.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000249550.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000249593.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000249595.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000249602.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000249637.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000249650.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000249684.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000249740.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000249803.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000249825.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000249849.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000249894.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000249898.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000249899.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000249996.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000250039.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000250069.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000250222.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000250234.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000250237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000250260.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000250284.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000250295.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000250295.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000250508.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000250600.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000250748.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000250764.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000250802.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000250820.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000250846.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000250900.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000251034.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000251075.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000251127.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000251136.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000251136.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000251148.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000251298.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000251323.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000251387.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000251387.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000251460.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000251523.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000251555.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000251665.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000251666.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000251867.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000253111.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000253112.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000253184.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000253210.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000253284.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000253315.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000253327.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000253327.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000253335.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000253385.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000253395.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000253404.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000253433.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000253445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000253552.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000253618.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000253632.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000253636.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000253720.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000253730.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000253741.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000253741.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000253744.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000253754.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000253819.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000253837.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000253878.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000253917.3 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000253948.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000253986.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000254223.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000254237.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000254248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000254263.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000254333.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000254340.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000254340.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000254353.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000254353.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000254363.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000254369.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000254409.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000254419.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000254419.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000254451.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000254458.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000254461.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000254485.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000254528.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000254577.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000254592.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000254592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000254602.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000254662.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000254671.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000254682.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000254691.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000254718.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000254733.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000254756.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000254762.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000254826.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000254837.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000254839.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000254854.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000254879.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000254910.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000254910.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000254911.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000254964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000255002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000255084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000255164.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000255176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000255182.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000255240.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000255247.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000255247.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000255248.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000255276.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000255306.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000255337.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000255343.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000255395.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000255414.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000255434.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000255443.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000255478.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000255520.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000255557.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000255568.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000255723.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000255857.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000255928.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000255970.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000255989.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000256124.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000256124.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000256271.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000256299.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000256433.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000256540.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000256582.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000256712.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000256712.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000256721.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000256802.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000256894.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000257004.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000257004.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000257027.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000257027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000257084.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000257139.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000257167.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000257167.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000257202.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000257285.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000257298.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000257449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000257488.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000257497.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000257534.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000257563.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000257596.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000257660.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000257698.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000257698.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000257759.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000257809.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000257815.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000257925.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000257931.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000257999.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000258048.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000258334.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000258344.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000258345.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000258400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000258428.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000258479.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000258486.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000258534.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000258534.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000258561.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000258561.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000258620.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000258646.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000258658.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000258704.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000258730.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000258730.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000258733.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000258813.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000258821.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000258891.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000258914.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000258929.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000258938.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000258940.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000259002.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000259062.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000259081.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000259103.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000259135.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000259182.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000259187.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000259188.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000259200.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000259200.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000259201.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000259201.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000259230.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000259298.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000259319.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000259376.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000259410.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000259415.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000259416.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000259448.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000259450.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000259456.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000259462.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000259474.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000259488.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000259499.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000259536.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000259553.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000259563.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000259590.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000259617.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000259644.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000259668.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000259673.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000259687.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000259701.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000259783.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000259804.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000259804.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000259818.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000259826.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000259877.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000259884.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000259901.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000260017.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000260032.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000260032.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000260037.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000260066.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000260081.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000260084.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000260086.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000260166.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000260171.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000260197.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000260206.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000260206.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000260231.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000260231.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000260233.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000260260.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000260273.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000260277.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000260278.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000260285.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000260317.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000260328.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000260328.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000260329.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000260351.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000260368.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000260369.2 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000260378.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000260423.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000260439.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000260464.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000260495.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000260495.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000260498.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000260515.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000260545.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000260545.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000260572.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000260579.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000260585.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000260589.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000260597.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000260597.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000260608.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000260618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000260626.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000260630.2 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000260650.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000260664.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000260671.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000260698.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000260706.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000260744.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000260778.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000260787.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000260790.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000260793.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000260793.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000260796.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000260804.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000260805.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000260816.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000260833.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000260927.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000260929.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000260936.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000260938.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000260954.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000260955.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000260955.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000260973.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000260977.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000260986.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000260992.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000261008.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000261019.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000261024.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000261040.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000261043.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000261043.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000261043.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000261068.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000261076.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000261094.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000261101.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000261114.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000261135.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000261135.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000261168.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000261168.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000261170.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000261207.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000261211.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000261216.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000261242.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000261242.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000261270.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000261324.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000261324.2 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000261326.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000261338.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000261346.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000261353.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000261366.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000261390.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000261390.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000261396.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000261404.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000261416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000261420.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000261430.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000261431.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000261437.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000261441.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000261442.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000261455.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000261455.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000261485.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000261490.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000261534.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000261596.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000261610.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000261697.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000261697.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000261716.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000261744.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000261754.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000261758.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000261770.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000261886.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000261886.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000261978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000262172.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000262202.3 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000262213.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000262313.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000262313.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000262319.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000262362.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000262380.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000262410.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000262468.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000262619.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000262678.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000262873.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000262905.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000262951.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000262952.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000262952.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000263050.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000263105.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000263182.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000263214.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000263293.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000263325.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000263338.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000263388.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000263531.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000263603.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000263612.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000263627.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000263753.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000263874.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000263893.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000263934.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000263975.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000263982.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000264015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000264222.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000264365.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000264421.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000264469.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000264569.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000264630.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000264660.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000264672.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000264672.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000264808.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000264812.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000264885.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000265091.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000265094.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000265206.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000265265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000265334.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000265458.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000265474.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000265490.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000265494.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000265519.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000265656.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000265778.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000266079.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000266088.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000266088.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000266176.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000266236.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000266261.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000266290.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000266371.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000266402.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000266498.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000266538.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000266598.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000266601.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000266644.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000266718.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000266718.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000266805.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000266901.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000266912.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000266935.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000266936.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000266941.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000266969.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000266993.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000266993.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000266999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000267009.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000267016.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000267042.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000267047.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000267093.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000267136.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000267141.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000267143.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000267159.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000267191.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000267213.3 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000267232.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000267246.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000267248.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000267268.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000267275.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000267285.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000267285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000267299.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000267304.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000267342.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000267347.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000267374.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000267394.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000267394.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000267397.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000267405.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000267432.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000267470.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000267470.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000267476.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000267479.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000267493.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000267502.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000267519.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000267549.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000267550.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000267560.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000267568.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000267568.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000267606.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000267651.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000267655.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000267658.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000267677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000267715.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000267730.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000267737.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000267750.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000267759.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000267764.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000267767.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000267834.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000268015.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000268047.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000268049.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000268157.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000268164.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000268189.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000268199.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000268201.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000268262.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000268340.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000268375.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000268392.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000268471.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000268499.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000268516.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000268518.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000268518.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000268520.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000268536.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000268544.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000268605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000268650.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000268751.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000268836.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000268842.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000268895.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000268947.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000269082.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000269086.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000269148.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000269191.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000269220.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000269246.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000269321.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000269392.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000269400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000269423.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000269463.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000269473.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000269473.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000269486.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000269640.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000269656.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000269696.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000269814.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000269815.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000269843.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000269867.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000269867.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000269896.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000269906.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000269925.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000269925.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000269929.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000269942.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000269958.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000269976.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000270009.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000270040.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000270041.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000270048.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000270062.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000270068.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000270102.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000270108.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000270109.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000270130.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000270130.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000270130.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000270133.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000270137.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000270137.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000270140.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000270159.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000270195.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000270210.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000270344.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000270346.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000270482.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000270523.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000270557.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000270562.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000270681.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000270755.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000270760.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000270820.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000270828.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000270933.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000270964.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000270988.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000271020.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000271086.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000271109.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000271200.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000271200.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000271259.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000271265.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000271314.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000271324.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000271327.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000271327.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000271366.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000271367.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000271401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000271590.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000271643.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000271646.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000271738.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000271751.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000271757.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000271762.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000271781.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000271788.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000271788.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000271833.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000271835.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000271845.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000271869.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000271869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000271871.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000271874.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000271914.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000271926.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000271963.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000271991.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000271993.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000271998.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000272003.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000272004.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000272023.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272024.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000272024.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000272033.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000272065.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000272071.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272077.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000272092.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000272130.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272142.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000272158.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000272172.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000272181.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272183.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000272192.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000272192.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000272198.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272216.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272239.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000272248.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000272248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000272273.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000272301.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272320.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272327.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000272361.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000272373.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272373.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000272374.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000272375.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000272416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272426.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272426.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000272438.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000272459.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000272463.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000272483.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000272505.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000272512.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000272524.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272524.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000272525.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000272525.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272544.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000272544.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000272562.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272567.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000272574.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000272630.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000272645.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000272646.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000272677.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000272689.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000272691.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000272702.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000272716.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272744.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272746.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272746.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000272761.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000272788.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272788.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000272788.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000272791.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272792.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000272795.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272798.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272799.1 |
Predicted lncRNA |
Sarcoma |
|
| IPA-3 |
ENSG00000272810.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000272828.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000272834.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000272848.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000272848.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000272864.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272870.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000272922.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000272927.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272942.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000272949.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000272954.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000272954.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000272954.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000272958.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000272960.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000272995.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000273001.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000273002.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000273004.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000273007.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000273014.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000273015.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000273018.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000273026.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000273038.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000273038.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000273059.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000273065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000273068.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000273091.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000273108.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000273123.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000273139.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000273143.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000273160.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000273162.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000273162.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| IPA-3 |
ENSG00000273174.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000273175.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000273176.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000273181.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000273186.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000273216.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000273230.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| IPA-3 |
ENSG00000273232.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000273237.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000273264.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| IPA-3 |
ENSG00000273270.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000273281.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000273284.1 |
Predicted lncRNA |
Esophageal cancer |
|
| IPA-3 |
ENSG00000273319.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| IPA-3 |
ENSG00000273325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| IPA-3 |
ENSG00000273355.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| IPA-3 |
ENSG00000273402.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000273416.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| IPA-3 |
ENSG00000273424.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000273443.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000273445.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| IPA-3 |
ENSG00000273447.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| IPA-3 |
ENSG00000273449.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000273471.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| IPA-3 |
ENSG00000273472.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| IPA-3 |
ENSG00000273492.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| IPA-3 |
ENSG00000273492.1 |
Predicted lncRNA |
Esophageal cancer |
|
